January 2022 net returns of 49.12 percent

Shelburne, Vermont, February 10, 2022, (Access Newswire) —Lemelson Capital Management, LLC (LCM), today announced returns for January 2022. 

In the month ending January 31, 2022, The Spruce Peak Fund LP's (SPF) performance was 49.12 percent net of all fees and expenses based on preliminary unaudited results.¹ The S&P 500 TR (the "benchmark"), which includes the reinvestment of dividends, returned minus (-5.17) percent during the same period. 

"We concluded January 2022 with better than average returns," said Fr. Emmanuel Lemelson, Chief Investment Officer, LCM “However, these returns are outliers, and Investors should not expect this sort of performance in the future," Lemelson concluded.

In 2021 Lemelson Capital Management posted combined returns of 56.05 percent net of all fees and expenses.²  The benchmark, S&P 500 TR returned 28.72 percent during the same period.

Lemelson Capital Management To Host January 2022 Investor Conference Call On February 11, 2022

To receive a copy of an investor presentation or to submit questions in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.

This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Short and long positions contribute to FYE 2021 combined¹ net returns of 56 percent.  Estimated MTD January 2022 net returns over 30 percent.²

Shelburne, Vermont, January 14, 2022, (Access Newswire) —Lemelson Capital Management, LLC (LCM), today announced financial results for FYE 2021.  The firm posted combined net returns of 56.05 percent for FYE 2021, comparing favorably against the benchmark S&P 500 Total Return Index,³ which returned 28.72 percent during the same period. 

As of January 13, 2022, estimated MTD net returns exceed 30 percent net of all fees and expenses.

"We concluded 2021 with a better than average rate of return and kicked off January 2022 with strong returns," said Fr. Emmanuel Lemelson, Chief Investment Officer. "Notably, Generac Holdings, Inc. (NYSE: GNRC), Revolve Group, Inc. (NYSE: RVLV) and Trex Company Inc (NYSE: TREX) contributed to our returns on the short side, while Berkshire Hathaway, Inc. (NYSE BRK.B) First American Financial (NYSE: FAF), and Progressive Insurance (NYSE: PGR) which we are long, performed well," Lemelson continued.  "However, investors should not expect these sorts of returns in the future," Lemelson cautioned.

Lemelson Capital Management To Host FY 2021 Investor Conference Call On January 14, 2022

To receive a copy of an investor presentation or to submit questions in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.

This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Fr. Emmanuel Lemelson Comments on Jury Verdict

Jury Verdict Finds Fr. Emmanuel "Not Liable" For Key Allegations

Shelburne, Vermont, November 5, 2021 —The Rev. Emmanuel Lemelson, CIO of Lemelson Capital Management, commented on the jury verdict which found the firm and its CIO "Not Liable" for The Securities and Exchange Commissions (SEC) allegations of a scheme to defraud, violations of the Investment Advisors Act of 1940 or commentary regarding Ligand Pharmaceuticals (NASDAQ: LGND) insolvency.  However, the jury did find Fr. Lemelson liable for some of the remaining challenged statements, including two comments made about a different company, Viking Therapeutics (NASDAQ: VKTX), which Lemelson did not trade in.  

Addressing the ruling, Lemelson commented; 

"We would like to thank the jury for their service, and verdict of "Not Liable" for the key allegations contained in the complaint.  After seven years, we chose to go to trial on these unprecedented charges," Lemelson said. "We intend to appeal the remaining adverse parts of the verdict," Lemelson added

A Boston federal jury on Friday absolved a Greek Orthodox priest of fraud claims in a U.S. Securities and Exchange Commission suit alleging he launched a short-and-distort scheme through his hedge fund. https://t.co/rpvBDj5O9d

— Law360 (@Law360) November 5, 2021

____________________________________

The case is: SEC v. Lemelson et. al.  [docket number 1:18-cv-11926]

About Lemelson Capital Management

Lemelson Capital Management, LLC is a private investment management firm focused on deep value and special situation investments.  For more information, visit: https://www.lemelsoncapital.com or follow on Twitter @LemelsonCapital 

About Rev. Fr. Emmanuel Lemelson

Rev. Fr. Emmanuel Lemelson is the Chief Investment Officer of Lemelson Capital Management, LLC, follow his work at www.amvona.com or on Twitter @Lemelson

For further information, please contact:

Lemelson Capital Management, LLC
Investor and Media Relations
Telephone: 1-802-332-3833

 For more background see:

• Motion to Dismiss here (October 25, 2018)
• Reply Brief here (November 21, 2018) 
• Opposition to The Securities and Exchange Commission's motion for protective order here  (January 7, 2020)
• Affidavit of Religious Affiliation here (March 30, 2020)
• Motion for Summary Judgement here (September 30, 2020)

On July 17, 2018, Fr. Emmanuel released a letter he provided members of The U.S. House Committee on Oversight and Government Reform, The U.S. Senate Special Committee on Aging and the SEC Office of the Inspector General, further outlining extensive alleged abuses of accounting, pharmaceutical reimbursement and classification guidelines and regulations by Ligand Pharmaceuticals. In the letter, Lemelson urged the Committees in both the House and the Senate to commence an investigation into these alleged abuses, as well as the Securities and Exchange Commission’s (SEC) failure to stop them.

Lemelson's full July 13, 2018 letter to Congress is available online here

His December 2016 letter to the U.S. Senate Special Committee on Aging, regarding the company, is available online here

Lemelson Capital Management To Host Q3 2021 Investor Conference Call On October 11, 2021

To receive a copy of an investor presentation or to submit questions in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.

This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Lemelson Capital Management To Host August 2021 Investor Conference Call On September 17, 2021

To receive a copy of an investor presentation or to submit questions in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.

This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Lemelson Capital Management To Host July 2021 Investor Conference Call On August 20, 2021

To receive a copy of an investor presentation in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.
This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Lemelson Capital Management To Host 1H 2021 Investor Conference Call On July 16, 2021

To receive a copy of an investor presentation in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.
This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Lemelson Capital Management To Host May 2021 Investor Conference Call On June 15, 2021

To receive a copy of an investor presentation in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.
This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Lemelson Capital Management To Host April 2021 Investor Conference Call On May 14, 2021

To receive a copy of an investor presentation in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.
This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Global star Mark Wahlberg calls in the big guns when he asks Lemelson Capital Management CIO and activist investor Fr. Emmanuel Lemelson to step in as a mentor.

Hold on to your seat because you won't want to miss a minute of this gripping six-part docuseries now streaming on #HBOMax

#WahlStreet #WahlStreetOnMax

Lemelson Capital Management To Host Q1, 2021 Investor Conference Call On April 15, 2021

To receive a copy of an investor presentation in advance, please contact investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it.
This call is for existing partners and prospective (qualified) investors only.
There are a limited number of lines available. This call is expected to be oversubscribed.
Call-in details will be provided upon registration approval.

Lemelson Capital Management To Host Q4, 2020 Investor Conference Call On January 15, 2021
 

To read the full Opposition click here or view on Scribd below.

"That is, the Commission promoted Ligand’s stock price in its Complaint, which was riddled with objectively false information, which dramatically overstated the financial condition of the company. Ironically, this is precisely the nature of its alleged market-manipulation claims the Commission brought against Fr. Emmanuel...

...with one [Ligand personnel] referring to some of the company’s own shareholders as “morons.”

Defendants' opposition to plaintiff's motion for partial summary judgment
October 30, 2020

Fig. 1 - Ligand Insider Sells

 For more background see:

• Motion to Dismiss here (October 25, 2018)
• Reply Brief here (November 21, 2018) 
• Opposition to The Securities and Exchange Commission's motion for protective order here  (January 7, 2020)
• Affidavit of Religious Affiliation here (March 30, 2020)
• Motion for Summary Judgement here (September 30, 2020)

Fr. Emmanuel Lemelson Files Opposition in SEC Fight over Ligand Pharmaceuticals (NASDAQ: LGND) by amvona on Scribd

On July 17, 2018, Fr. Emmanuel released a letter he provided members of The U.S. House Committee on Oversight and Government Reform, The U.S. Senate Special Committee on Aging and the SEC Office of the Inspector General, further outlining extensive alleged abuses of accounting, pharmaceutical reimbursement and classification guidelines and regulations by Ligand Pharmaceuticals. In the letter, Lemelson urged the Committees in both the House and the Senate to commence an investigation into these alleged abuses, as well as the Securities and Exchange Commission’s (SEC) failure to stop them.

Lemelson's full July 13, 2018 letter to Congress is available online here

His December 2016 letter to the U.S. Senate Special Committee on Aging, regarding the company, is available online here